PRIMARY OPEN-ANGLE GLAUCOMA (POAG)
Clinical trials for PRIMARY OPEN-ANGLE GLAUCOMA (POAG) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY OPEN-ANGLE GLAUCOMA (POAG) trials appear
Sign up with your email to follow new studies for PRIMARY OPEN-ANGLE GLAUCOMA (POAG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can mexidol help preserve vision in glaucoma patients?
Disease control CompletedThis study tested different doses of the drug Mexidol in 102 adults with moderate to advanced primary open-angle glaucoma. The goal was to see if the drug could improve or protect vision compared to a placebo. Participants received either Mexidol or a placebo over several months,…
Matched conditions: PRIMARY OPEN-ANGLE GLAUCOMA (POAG)
Phase: PHASE2 • Sponsor: Pharmasoft • Aim: Disease control
Last updated May 26, 2026 11:05 UTC
-
Can a nerve protector slow glaucoma damage?
Disease control CompletedThis study tested whether a drug called Mexidol can protect the optic nerve in people with advanced primary open-angle glaucoma. Eighty adults with controlled eye pressure took part. The goal was to see if the treatment helps maintain vision and nerve function over time.
Matched conditions: PRIMARY OPEN-ANGLE GLAUCOMA (POAG)
Phase: PHASE4 • Sponsor: Pharmasoft • Aim: Disease control
Last updated May 26, 2026 11:00 UTC